Prognosis of IPF patients with comorbid lung cancer: Preventing immortal time bias will make the analysis more valuable

Respirology. 2023 Feb;28(2):196-197. doi: 10.1111/resp.14436. Epub 2022 Dec 12.

Authors

Sho Yamada¹, Satoshi Ikeda¹, Toshihiro Misumi², Akimasa Sekine¹, Takashi Ogura¹

Affiliations

¹ Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan.
² Department of Data Science, National Cancer Center Hospital East, Kashiwa, Japan.

PMID: 36509428
DOI: 10.1111/resp.14436

No abstract available

Keywords: antifibrotics; idiopathic pulmonary fibrosis; immortal time bias; lung cancer; mortality.

Publication types

Letter
Comment

MeSH terms

Humans
Idiopathic Pulmonary Fibrosis* / complications
Idiopathic Pulmonary Fibrosis* / epidemiology
Lung Neoplasms* / complications
Lung Neoplasms* / epidemiology
Prognosis